Moorin Jay

FollowCreate a free account to set a filing alert.

Director at Paratek Pharmaceuticals, Inc. · on record since May 17, 2006
10% owner at NOVADEL PHARMA INC · on record since Apr 14, 2006
10% owner at CADENCE PHARMACEUTICALS INC · on record since Oct 31, 2006
10% owner at AVANIR PHARMACEUTICALS, INC. · on record since Aug 29, 2008
10% owner at ACHILLION PHARMACEUTICALS INC · on record since Aug 21, 2008
10% owner at CYPRESS BIOSCIENCE INC · on record since Oct 24, 2003
Director at PHARMION CORP · on record since Nov 5, 2003
Director at EAGLE PHARMACEUTICALS, INC. · on record since Feb 20, 2014
10% owner at EAGLE PHARMACEUTICALS, INC. · on record since Feb 20, 2014
Director at Pegasi Energy Resources Corporation. · on record since Feb 10, 2014
10% owner at ALGORX PHARMACEUTICALS INC · on record since May 22, 2014
10% owner at IMMUNE DESIGN CORP. · on record since Jul 31, 2014
Director at Arno Therapeutics, Inc · on record since Jan 14, 2016
10% owner at Molecular Templates, Inc. · on record since Feb 4, 2005
10% owner at UroGen Pharma Ltd. · on record since Jul 20, 2017
10% owner at PALATIN TECHNOLOGIES INC · on record since Dec 1, 2005

Insider trading activity of Moorin Jay

Transactions on record: 105; since Oct 24, 2003

Purchases: 18; $10.8M

Sales: 41; $21.1M

Companies traded: 12; last filing Nov 29, 2017

Figures computed from official regulatory filings — .

Companies where Moorin Jay has traded

UroGen Pharma Ltd.2 tx · $8.5M · Nov 29, 2017
24 tx · $5M · May 15, 2017
1 tx · Jan 14, 2016
11 tx · $6.4M · May 13, 2015
2 tx · $62.5B · Jan 20, 2015
10 tx · $3M · Feb 13, 2012
2 tx · $2M · Dec 18, 2009
17 tx · $5M · Oct 13, 2009
23 tx · $219.6K · Aug 31, 2007
10 tx · $2.5M · Jan 19, 2007
1 tx · Jun 4, 2004
2 tx · $154.5K · Oct 24, 2003

Track record of Moorin Jay

Statistical track record

Free account

Purchases: 24

Last buy: Jan 9, 2015

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Moorin Jay

Co-insiders of Moorin Jay

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
UroGen Pharma Ltd.Listing on record	Nov 29, 2017	Sell	-31,491	41.12 USD	$1.3M		SEC
UroGen Pharma Ltd.Listing on record	Nov 29, 2017	Sell	-177,807	40.51 USD	$7.2M	Unusual size	SEC
EAGLE PHARMACEUTICALS, INC.Listing on record	May 15, 2017	Other	-3,584,087	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
EAGLE PHARMACEUTICALS, INC.Listing on record	May 15, 2017	Other	149,107	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
EAGLE PHARMACEUTICALS, INC.Listing on record	May 15, 2017	Other	149,107	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Arno Therapeutics, IncListing unverified	Jan 14, 2016	AwardD (derivative)	88,648	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
EAGLE PHARMACEUTICALS, INC.Listing on record	Jan 5, 2016	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IMMUNE DESIGN CORP.Listing unverified	May 13, 2015	Sell	-22,607	22.26 USD	$503.2K		SEC
IMMUNE DESIGN CORP.Listing unverified	May 13, 2015	Sell	-155,000	21.50 USD	$3.3M	Unusual size	SEC
EAGLE PHARMACEUTICALS, INC.Listing on record	Apr 22, 2015	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IMMUNE DESIGN CORP.Listing unverified	Apr 21, 2015	Sell	-14,167	26.35 USD	$373.3K		SEC
IMMUNE DESIGN CORP.Listing unverified	Apr 21, 2015	Sell	-18,861	26.67 USD	$503K		SEC
IMMUNE DESIGN CORP.Listing unverified	Apr 21, 2015	Sell	-12,792	26.44 USD	$338.2K		SEC
IMMUNE DESIGN CORP.Listing unverified	Mar 18, 2015	Sell	-100	27.02 USD	$2.7K		SEC
IMMUNE DESIGN CORP.Listing unverified	Mar 18, 2015	Sell	-10,309	25.43 USD	$262.2K		SEC
IMMUNE DESIGN CORP.Listing unverified	Mar 18, 2015	Sell	-100	27.04 USD	$2.7K		SEC
EAGLE PHARMACEUTICALS, INC.Listing on record	Mar 18, 2015	AwardD (derivative)	5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IMMUNE DESIGN CORP.Listing unverified	Mar 18, 2015	Sell	-500	26.99 USD	$13.5K		SEC
IMMUNE DESIGN CORP.Listing unverified	Mar 18, 2015	Sell	-19,300	26.56 USD	$512.6K		SEC
IMMUNE DESIGN CORP.Listing unverified	Mar 18, 2015	Sell	-20,000	25.94 USD	$518.8K		SEC
Pegasi Energy Resources Corporation.Listing unverified	Jan 20, 2015	BuyD (derivative)	694,444	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	Cluster	SEC
Pegasi Energy Resources Corporation.Listing unverified	Jan 20, 2015	BuyD (derivative)	250,000	250,000.00 USD	$62.5B	ClusterUnusual size	SEC
EAGLE PHARMACEUTICALS, INC.Listing on record	May 2, 2014	AwardD (derivative)	4,680	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
EAGLE PHARMACEUTICALS, INC.Listing on record	Feb 20, 2014	OtherD (derivative)	-1,614	—	n/a (No price was disclosed in the filing)		SEC
EAGLE PHARMACEUTICALS, INC.Listing on record	Feb 20, 2014	OtherD (derivative)	-1,028,613	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
UroGen Pharma Ltd.Listing on record	Nov 29, 2017	Sell	-31,491	41.12 USD	$1.3M		SEC
UroGen Pharma Ltd.Listing on record	Nov 29, 2017	Sell	-177,807	40.51 USD	$7.2M	Unusual size	SEC
EAGLE PHARMACEUTICALS, INC.Listing on record	May 15, 2017	Other	-3,584,087	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
EAGLE PHARMACEUTICALS, INC.Listing on record	May 15, 2017	Other	149,107	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
EAGLE PHARMACEUTICALS, INC.Listing on record	May 15, 2017	Other	149,107	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Arno Therapeutics, IncListing unverified	Jan 14, 2016	AwardD (derivative)	88,648	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
EAGLE PHARMACEUTICALS, INC.Listing on record	Jan 5, 2016	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IMMUNE DESIGN CORP.Listing unverified	May 13, 2015	Sell	-22,607	22.26 USD	$503.2K		SEC
IMMUNE DESIGN CORP.Listing unverified	May 13, 2015	Sell	-155,000	21.50 USD	$3.3M	Unusual size	SEC
EAGLE PHARMACEUTICALS, INC.Listing on record	Apr 22, 2015	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IMMUNE DESIGN CORP.Listing unverified	Apr 21, 2015	Sell	-14,167	26.35 USD	$373.3K		SEC
IMMUNE DESIGN CORP.Listing unverified	Apr 21, 2015	Sell	-18,861	26.67 USD	$503K		SEC
IMMUNE DESIGN CORP.Listing unverified	Apr 21, 2015	Sell	-12,792	26.44 USD	$338.2K		SEC
IMMUNE DESIGN CORP.Listing unverified	Mar 18, 2015	Sell	-100	27.02 USD	$2.7K		SEC
IMMUNE DESIGN CORP.Listing unverified	Mar 18, 2015	Sell	-10,309	25.43 USD	$262.2K		SEC
IMMUNE DESIGN CORP.Listing unverified	Mar 18, 2015	Sell	-100	27.04 USD	$2.7K		SEC
EAGLE PHARMACEUTICALS, INC.Listing on record	Mar 18, 2015	AwardD (derivative)	5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IMMUNE DESIGN CORP.Listing unverified	Mar 18, 2015	Sell	-500	26.99 USD	$13.5K		SEC
IMMUNE DESIGN CORP.Listing unverified	Mar 18, 2015	Sell	-19,300	26.56 USD	$512.6K		SEC
IMMUNE DESIGN CORP.Listing unverified	Mar 18, 2015	Sell	-20,000	25.94 USD	$518.8K		SEC
Pegasi Energy Resources Corporation.Listing unverified	Jan 20, 2015	BuyD (derivative)	694,444	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	Cluster	SEC
Pegasi Energy Resources Corporation.Listing unverified	Jan 20, 2015	BuyD (derivative)	250,000	250,000.00 USD	$62.5B	ClusterUnusual size	SEC
EAGLE PHARMACEUTICALS, INC.Listing on record	May 2, 2014	AwardD (derivative)	4,680	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
EAGLE PHARMACEUTICALS, INC.Listing on record	Feb 20, 2014	OtherD (derivative)	-1,614	—	n/a (No price was disclosed in the filing)		SEC
EAGLE PHARMACEUTICALS, INC.Listing on record	Feb 20, 2014	OtherD (derivative)	-1,028,613	—	n/a (No price was disclosed in the filing)		SEC